| Dr Kristopher Shawn Lybarger, DO | |
|
2340 E Meyer Blvd Bldg 2, Ste 546, Kansas City, MO 64132-1105 | |
| (816) 926-0777 | |
| (816) 926-0707 |
| Full Name | Dr Kristopher Shawn Lybarger |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 2340 E Meyer Blvd Bldg 2, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013172022 | NPI | - | NPPES |
| 102699106 | Medicaid | PA | |
| 2697299 | Other | PA | HIGHMARK BLUE SHIELD |
| 30120311 | Other | PA | AMERIHEALTH MERCY - WMG |
| 1609940 | Other | PA | GATEWAY |
| 418499 | Other | PA | UPMC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centerpoint Medical Center | Independence, MO | Hospital |
| Research Medical Center | Kansas city, MO | Hospital |
| Overland Park Reg Med Ctr | Overland park, KS | Hospital |
| Menorah Medical Center | Overland park, KS | Hospital |
| Golden Valley Memorial Hospital | Clinton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Oncology Associates Llc | 3779635172 | 57 |
| Midwest Oncology Associates Llc | 3779635172 | 57 |
News Archive
Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a campaign to generate public support for efforts to eliminate mother-to-child transmission of HIV by 2015, the BBC reports. "The Born HIV Free campaign comes at a critical time, with the fund seeking donations of up to $20bn over the next three years," the BBC continues.
Cordis Corporation today announced that a U.S. District Court jury in Wilmington, Delaware found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare metal stents infringe Cordis' pioneering Palmaz patent for balloon expandable stents
A new approach to estimating tumour growth based on breast screening results from almost 400,000 women is published in BioMed Central's open access journal, Breast Cancer Research.
The outbreak of severe acute respiratory syndrome (SARS) in 2002 was a loud wake-up call for researchers studying infectious diseases.
› Verified 9 days ago
| Entity Name | University Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669456257 PECOS PAC ID: 1153235825 Enrollment ID: O20031117000701 |
News Archive
Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a campaign to generate public support for efforts to eliminate mother-to-child transmission of HIV by 2015, the BBC reports. "The Born HIV Free campaign comes at a critical time, with the fund seeking donations of up to $20bn over the next three years," the BBC continues.
Cordis Corporation today announced that a U.S. District Court jury in Wilmington, Delaware found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare metal stents infringe Cordis' pioneering Palmaz patent for balloon expandable stents
A new approach to estimating tumour growth based on breast screening results from almost 400,000 women is published in BioMed Central's open access journal, Breast Cancer Research.
The outbreak of severe acute respiratory syndrome (SARS) in 2002 was a loud wake-up call for researchers studying infectious diseases.
› Verified 9 days ago
| Entity Name | Midwest Oncology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699911677 PECOS PAC ID: 3779635172 Enrollment ID: O20090716000071 |
News Archive
Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a campaign to generate public support for efforts to eliminate mother-to-child transmission of HIV by 2015, the BBC reports. "The Born HIV Free campaign comes at a critical time, with the fund seeking donations of up to $20bn over the next three years," the BBC continues.
Cordis Corporation today announced that a U.S. District Court jury in Wilmington, Delaware found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare metal stents infringe Cordis' pioneering Palmaz patent for balloon expandable stents
A new approach to estimating tumour growth based on breast screening results from almost 400,000 women is published in BioMed Central's open access journal, Breast Cancer Research.
The outbreak of severe acute respiratory syndrome (SARS) in 2002 was a loud wake-up call for researchers studying infectious diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristopher Shawn Lybarger, DO 2340 E Meyer Blvd Bldg 2, Ste 546, Kansas City, MO 64132-1105 Ph: (816) 926-0777 | Dr Kristopher Shawn Lybarger, DO 2340 E Meyer Blvd Bldg 2, Ste 546, Kansas City, MO 64132-1105 Ph: (816) 926-0777 |
News Archive
Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a campaign to generate public support for efforts to eliminate mother-to-child transmission of HIV by 2015, the BBC reports. "The Born HIV Free campaign comes at a critical time, with the fund seeking donations of up to $20bn over the next three years," the BBC continues.
Cordis Corporation today announced that a U.S. District Court jury in Wilmington, Delaware found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare metal stents infringe Cordis' pioneering Palmaz patent for balloon expandable stents
A new approach to estimating tumour growth based on breast screening results from almost 400,000 women is published in BioMed Central's open access journal, Breast Cancer Research.
The outbreak of severe acute respiratory syndrome (SARS) in 2002 was a loud wake-up call for researchers studying infectious diseases.
› Verified 9 days ago
Susan Marie Mou, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Charlotte St, Kansas City, MO 64108 Phone: 816-404-7820 Fax: 816-404-8159 | |
Ronald Edward Brunnabend Ii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Ste 598, Kansas City, MO 64132 Phone: 816-444-6888 | |
Douglas R Perryman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4400 Broadway Ste 302, Kansas City, MO 64111 Phone: 816-931-9344 Fax: 816-931-4168 | |
Anupama Kotha, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-3584 Fax: 816-932-5873 | |
Zachary James Alholm, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0880 | |
Gerald Lee Miller Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6400 Prospect, #598, Kansas City, MO 64132 Phone: 816-444-6888 Fax: 816-444-1375 |